MIRA INFORM REPORT

 

 

Report Date :

24.10.2008

 

IDENTIFICATION DETAILS

 

Name :

GLATT (INDIA) PHARMA ENGINEERING PRIVATE LIMITED

 

 

Registered Office :

13 Ground Floor, Palam Marg, Vasant Vihar, New Delhi – 110057

 

 

Country :

India

 

 

Date of Incorporation :

13.12.2007

 

 

Com. Reg. No.:

171406

 

 

CIN No.:

[Company Identification No.]

U85100DL2007FTC171406

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELG10923D

 

 

PAN No.:

[Permanent Account No.]

AADCG0052E

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Service provider to pharmaceutical Companies 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

--

 

 

Status :

New Company

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

The company is a subsidiary of Glatt Ingenieurtechnik GmbH, Germany. Subject is a part of Glatt Group, Worldwide. Trade relations are fair. Payments are correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Anupnath Singhal

Designation :

Manager

Date :

22.10.2008

 

 

LOCATIONS

 

Registered Office :

13 Ground Floor, Palam Marg, Vasant Vihar, New Delhi – 110057, India

Tel. No.:

91- 11- 46052960/ 63

Fax No.:

91- 11- 46052964

E-Mail :

info@glatt-india.com

Website :

www.glatt.com

 

 

Branch Office :

B – 296, Okhla Industrial Area, Phase 1, New Delhi – 110020, India

E-Mail :

vohrasahni@vsnl.com

 

 

Overseas Branches 1 :

Glatt Ingenieurtechnik GmbH

Nordstr. 12, 99427 Weimar, Germay

Tel. No.:

+49364347 - 1506

 

 

Overseas Branches 2 :

Glatt Ingenieurtechnik GmbH

Ul. Obrucheva, 23, korp. 3, 117630, Moscow, Russia

Tel. No.:

+7495787 – 4289

Fax No.:

+7495787 – 4291

E-Mail :

Info.glatt.moscow@mastertelecom.ru

 

 

DIRECTORS

 

Name :

Mr. Bernd Walter Kreyer

Designation :

Director

Address :

Neckarstr 44, Neu Isenberg - 63263

Date of Birth/Age :

03.10.1953

 

 

Name :

Mr. Reinhard Harald Boeber

Designation :

Director

Address :

Robert – Koch – Str. 8, Weimar – 99425

Date of Birth/Age :

21.05.1949

 

 

KEY EXECUTIVES

 

Name :

Mr. Anupnath Singhal

Designation :

Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

No. of Shares

Glatt Ingenieurtechnik GmbH

 

675000

 

 

BUSINESS DETAILS

 

Line of Business :

Service provider to pharmaceutical Companies 

 

 

Terms :

 

Selling :

Advance

 

 

GENERAL INFORMATION

 

Customers :

Pharmaceutical Companies

 

 

No. of Employees :

2

 

 

Bankers :

Deutsche Bank, New Delhi

 

 

 

Auditors :

 

Name :

Mr. L. N. Sahari

Chartered Accountant

 

 

CAPITAL STRUCTURE

 

AS ON 08.07.2008

 

Authorised Capital :

No. of Shares

Type

Value

Amount

1000000

Equity Shares

Rs. 10/- Each

Rs.10.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

675000

Equity Shares

Rs. 10/- Each

Rs.6.750 Millions

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

Note: No financial are available as the subject is a new company

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Notes:

The registered office of the company has been shifted from B – 296, Okhla Industrial Area, Phase 1, New Delhi – 110020, India to 13 Ground Floor, Palam Marg, Vasant Vihar, New Delhi – 110057, India with effect from 08.07.2008

 

 

THE HISTORY OF THE GLATT GROUP COMPANIES

 

Glatt the pioneer of fluid bed technology

After establishing the company in 1954 in Binzen, by 1959 Werner Glatt, together with just a dozen employees, had designed and constructed the world's first fluid bed plant suitable for industrial application in the pharmaceutical industry. His credo and his success formula was "Satisfied customers". The company's main customer base lay in the solid processing sectors of the pharmaceutical industry. Glatt was instrumental in establishing and continuously further developing this technology.Used initially as pure drying systems, through the use of suitable nozzle systems the fluid bed apparatus was turned into a granulator, and with the relevant further developments (Wurster system) also a particle coater. In all these developments, Glatt has always been the one to set the standard.

International Group of Companies

Glatt's international activity developed out of an increasing base of satisfied customers and growing international demand. In 1971, Glatt AG was founded in Switzerland, followed in 1973 by Glatt Air Techniques (GAT) in Ramsey, USA. Glatt AG was instrumental in launching a second product family onto the market: the Glatt coater.
In the USA, a second Technology Center was established alongside Binzen, so offering overseas customers the opportunity to test and optimize their machines, products and processes.Within the course of just a few years, other sales companies were established in the most important markets: Glatt Pharmatech in Dijon, France. Glatt Protech in the UK, Glatt Ireland and Glatt Norden in Denmark. In other countries, trade agreements with concluded with reputable trading firms.All this with one focal aim in mind: To improve customer support through better proximity.

From apparatus maker to system supplier

1989 was a historic year for Germany. The advent of German Unity brought about major changes for Glatt too. Reiner Nowak took over as Chief Executive of Werner Glatt and made the most of opportunities thrown up by the new development taking place in Germany.1991 saw the foundation of Glatt Ingenieurtechnik (GIT) in Weimar. Almost simultaneously, Glatt Systemtechnik (GST) was entered in the Commercial Register in Dresden.
Both companies added major new business fields to the Glatt portfolio: The production firm GST expanded the existing production range to include components, machines and units in the field of product handling. GIT in Weimar contributed extensive expertise from the field of continuous fluid bed technology. This company also specialized in consultancy, planning and implementation for complete process lines through to turnkey factories.

Glatt today

Today, the Glatt corporation is a truly global company group. It employs a workforce of over 1500 at its various Locations, and also works with over 50 permanent Agencies which act as local points of contact for customers around the world.People's ideas and expectations change in the same way as does the economic climate. But there is one thing which has not changed in almost 50 years: Their focus on customer satisfaction.

OTHER COMPANIES AND PARTNERS OF THE GLATT GROUP

 

·         ADD Advanced Drug Delivery Technologies AG

                   Pharmaceutical development for solids.

 

·         IPC Process Center GmbH

                   Contract manufacturing for pharmaceuticals, food/ feed and fine chemicals.

 

·         MCS-RATIO GmbH

MidMarket Consulting & Solutions

ERP and documentation management systems, control engineering, process visualization, validation.

 

·         Pharmatronic AG

Automation, qualification and validation, calibration.

Process engineering and facility planning,

 

·         Ramsey Design Group

Engineering, facility design, project management, automation, validation,

 

·         TTC Technology Traininrg Center

Training, instruction, seminars, symposia.

 

 

ADD Advanced Drug Delivery Technologies AG

Company foundation: 1998

 

Focus:

Ø       Pharmaceutical development of modern, innovative solid drug dosage forms.

Ø       State-of-the-art laboratory facilities. Close cooperation with the University of Basle.

 

Contact:

Advanced Drug Delivery Technologies AG

Kägenstrasse 17

4153 Reinach

Switzerland

Telephone: +41 –61 7159700

Telefax: +41 –61 7159701

email: info@addtechnologies.com

internet: www.addtechnologies.com

 

IPC Process Center GmbH

Company foundation: 1993

 

Focus:

Ø       Contract manufacturing for pharmaceuticals, food/feed and fine chemicals. GMP and non-GMP production.

Ø       Modern production facilities and state-of-the-art plant engineering.

 

Contact:

IPC Process Center GmbH

Grunaer Weg 26

01277 Dresden

Germany

Telephone: +49 –351 2584-0

Telefax: +49 –351 2584-328

email: info@ipc-dresden.de

internet: www.ipc-dresden.de

 

MCS-RATIO GmbH - MidMarket Consulting & Solutions

Company foundation: 2001

 

Focus:

Ø       Organization, consulting, conception, development and introduction of ERP and documentation management

Ø       Systems, Implementation of systems for control engineering and process visualization.

 

Contact:

MCS-RATIO GmbH

MidMarket Consulting & Solutions

Gartenstraße 2

78126 Königsfeld

Germany

Telephone: +49 –7725 9174-0

Telefax: +49 –7725 9174-39

email: info@mcs-ratio.de

internet: www.mcs-ratio.de

 

Pharmatronic AG

Company foundation: 1985

 

Focus:

Ø       Automation engineering

Ø       Control engineering

Ø       Electronic data processing connection concepts

Ø       Validation, qualification, calibration

Ø       Process engineering and facility planning

 

Contact:

Pharmatronic AG

Hohenrainstraße 10

4133 Pratteln

Switzerland

Telephone: +41 –61 826-9726

Telefax: +41 –61 826-9727

email: mail@pharmatronic.ch

internet: www.pharmatronic.ch

 

Ramsey Design Group

Foundation: 1998

 

Focus:

Ø       Facilities engineering

Ø       Project management

Ø       Construction management

Ø       Automation integration

Ø       Process simulation

Ø       Validation services

Ø       Plant optimization

Ø       21 CFR Part 11 consultation & remediation services

 

Contact:

Ramsey Design Group

A Division of Glatt Air Techniques

20 Spear Road Ramsey

NJ 07446

USA

Telephone: +1 -201 825-1391 

Telefax: +1 -201 825-0389

email: info@ramseydesign.com

internet: www.ramseydesign.com

 

 

TTC Technology Training Center

Foundation: 1998

 

Focus:
TTC Binzen offers a wide range of seminars and workshops for professional users with focus firmly on practical application for industry (pharmaceuticals, food /feed, cosmetics, chemicals etc.)

 

Contact:

TTC Technology Training Center

Werner-Glatt-Straße 1

79589 Binzen

Germany

Telephone: +49 –7621 664-308

Telefax: +49 –7621 664-632

email: TTC@ttc-binzen.de

internet: www.ttc-binzen.de

 

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.49.79

UK Pound

1

Rs.81.27

Euro

1

Rs.63.91

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

-

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

-

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

38

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions